Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 5,262 | 719 | 717 | 219 | 809 |
| Accounts receivable | -18,447 | -457 | -5,559 | 28,283 | -23,598 |
| Accounts payable and accrued liabilities | 10,567 | 5,362 | -4,117 | N/A | 7,117 |
| Other Working Capital | -13,904 | 2,119 | -13,254 | 31,964 | -16,042 |
| Other Operating Activity | 3,245 | -10,569 | -9,457 | -50,016 | 16,352 |
| Operating Cash Flow | $-13,277 | $-2,826 | $-31,670 | $10,450 | $-15,362 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 105 | -177 | -347 | N/A | N/A |
| Purchase Of Investment | -122,774 | -114,042 | -142,397 | -120,809 | -170,229 |
| Sale Of Investment | 102,996 | 120,525 | 167,766 | 118,207 | 120,432 |
| Other Investing Activity | -28 | -11,914 | -162 | -416 | -421 |
| Investing Cash Flow | $-19,701 | $-5,608 | $24,860 | $-3,018 | $-50,218 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -2,332 | 1,140 | 1,639 | 688 | 0 |
| Financing Cash Flow | $-2,332 | $1,140 | $1,639 | $688 | $0 |
| Beginning Cash Position | 81,707 | 89,001 | 94,172 | 86,052 | 151,632 |
| End Cash Position | 46,397 | 81,707 | 89,001 | 94,172 | 86,052 |
| Net Cash Flow | $-35,310 | $-7,294 | $-5,171 | $8,120 | $-65,580 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,277 | -2,826 | -31,670 | 10,450 | -15,362 |
| Capital Expenditure | N/A | -227 | -509 | N/A | N/A |
| Free Cash Flow | -13,277 | -3,053 | -32,179 | 10,450 | -15,362 |